Lee Karras

CEO, Halo

Articles by Lee Karras

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

August 14th 2026

Lee Karras, CEO, Halo discusses the company's new sterile fill-finish platform, Apotex partnership, and injectable onshoring strategy.

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

ByLee Karras,Zachary Zubulake

August 11th 2026

Lee Karras CEO, Halo Pharma ties the move to US injectable capacity along with an introduction to Halo’s new sterile fill-finish platform before GMP qualification.

Latest Updated Articles

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
August 14th 2026

Lee Karras

Articles by Lee Karras

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

Latest Updated Articles

Trending on Pharmaceutical Technology

Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

What to Know from the FDA’s End of August Activity

Pharma's Next AI Problem Is Authority

Strategies to Maximize Stability of Emerging Biologics